The purpose of this study is to characterize the current patterns of care for patients with hormone-receptor-positive, advanced breast cancer who have failed one prior endocrine therapy in Brazil. To investigate patient-related, disease-related and physician-related characteristics that correlate with the use of either endocrine treatment or chemotherapy in such patients. And to evaluate patients' understanding of the treatment options and their participation in the choice.
Study Type
OBSERVATIONAL
Enrollment
7
Research Site
Rio de Janeiro, Rio de Janeiro, Brazil
Research Site
Porto Alegre, Rio Grande do Sul, Brazil
Research Site
São Paulo, São Paulo, Brazil
Research Site
Belo Horizonte, Brazil
To assess the treatment choice by the medical oncologist for each patient.
Time frame: 12 months
To assess determinants of treatment choice
Time frame: 12 months
To assess the duration of treatment with chemotherapy or endocrine therapy
Time frame: 12 months
To evaluate the rate of treatment continuation at 6 months
Assess the profile of adverse events with each treatment modality and assess patient participation and understanding in treatment choice
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Research Site
Mogi das Cruzes, Brazil
Research Site
Ribeirão Preto, Brazil